Updates to COVID-19 Vaccine Eligibility Requirements

Effective April 1, more California residents can be vaccinated

Persons ages 65 and older

Sector groups

Persons ages 16 and older with one of the following high-risk medical conditions or disabilities are eligible for the COVID-19 vaccine.

Cancer, current with weakened immune system.
Chronic kidney disease, stage 4 or above.
Chronic pulmonary disease, oxygen dependent.
Down syndrome.
Solid organ transplant, leading to a weakened immune system.
Pregnancy.
Sickle cell disease.
Heart conditions, such as heart failure, coronary artery disease or cardiomyopathies (but not hypertension).
Severe obesity (Body Mass Index ≥ 40 kg/m²).
Type 2 diabetes mellitus with a hemoglobin A1c level greater than 7.5%.

OR if, as a result of a developmental or other significant high-risk disability, one or more of the following criteria applies:
A COVID-19 infection is likely to result in severe life-threatening illness or death.
Getting COVID-19 will limit the person’s ability to receive ongoing care or services vital to their well-being and survival.
Providing adequate and timely COVID-19 care will be particularly challenging as a result of the individual’s disability.
Proof for high-risk conditions or disabilities
1. Residents are not required to provide documentation of high-risk medical conditions and/or disabilities.
2. Residents are required to sign a self-attestation that they meet the criteria for the high-risk medical conditions and/or disabilities outlined on page 1.

AS OF APRIL 1, 2021

All individuals age 50 or older are eligible for vaccination.

AS OF APRIL 15, 2021

Every California resident age 16 or older is eligible for vaccination.

Additional resources on COVID-19 vaccine eligibility requirements

Resource	Link
Vaccinate All 58	https://vaccinateall58.com
California Department of Public Health	www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/vaccine-high-risk-factsheet.aspx
Department of Managed Health Care All Plan Letter 21-012	https://dmhc.ca.gov/Portals/0/Docs/DO/APL21-012-COVID-19VaccinePrioritization.pdf

Providers